The COST-UTILITY ANALYSIS OF FOUR CHELATION REGIMENS FOR ?-THALASSEMIA MAJOR: A CHINESE PERSPECTIVE. Mediterr J Hematol Infect Dis 2020, 12 (1), e2020029. https://doi.org/10.4084/mjhid.2020.029.